Skip to main content
Atrás
Watch Compare

Tenaya Therapeutics, Inc.

Calidad de datos: 83%
TNYA
Nasdaq Manufacturing Chemicals
$0.69
▼ $0.05 (-6.76%)
Cap. Mercado: 160.71 M
Precio
$0.74
Cap. Mercado
160.71 M
Rango del Día
—
Rango de 52 Semanas
—
Volumen
—
Apertura —
Promedio 50D / 200D
—
Promedio 50D / 200D
—

Quick Summary

Puntos Clave

Negative free cash flow of -68.88 M

Crecimiento

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-99.18%
Below sector avg (-53.34%)
ROIC-73.27%
Net MarginN/A
Op. MarginN/A

Seguridad

Debt / Equity
N/A
Current Ratio4.64
Interest CoverageN/A

Valoración

PE (TTM)
-1.77
Below sector avg (-1.47)
P/B Ratio1.94
EV/EBITDAN/A
Dividend YieldN/A

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Manufacturing (1364 pares)
Métrica Acción Mediana del Sector
P/E -1.8 -1.5
P/B 1.9 1.6
ROE % -99.2 -53.3
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

Precio Objetivo de Analistas

7 analistas
Buy
Actual
$0.69
+1204.3%
Objetivo
$9.00
$2.00
$3.00
$40.00
Pronóstico
P/E Futuro -1.53
EPS Futuro -$0.45
Ingresos Est. 0.0

Estimaciones de Ganancias

Período EPS Est. Ingresos Est. Analistas
FY2027 -$0.45
-$0.59 – -$0.29
 0.0 5
FY2026 -$0.43
-$0.59 – -$0.27
 10.00 M 8

Sorpresas de Ganancias

Últimos 4 trimestres
Trimestre EPS Est. EPS Real Sorpresa
Q42025 -$0.12 -$0.12 +1.0%
Q32025 -$0.15 -$0.12 +19.3%
Q22025 -$0.19 -$0.14 +24.8%
Q12025 -$0.21 -$0.24 -17.1%

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -90.60 M
ROE -99.18% ROA -79.78%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -68.88 M
ROIC -73.27% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 4.64
Interest Coverage N/A Asset Turnover N/A
Working Capital 48.03 M Tangible Book Value 82.87 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1.77 Forward P/E N/A
P/B Ratio 1.94 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -42.86%
Market Cap 160.71 M Enterprise Value 104.40 M
Per Share
EPS (Diluted TTM) -0.59 Revenue / Share N/A
FCF / Share -0.32 OCF / Share -0.31
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 76.03%
SBC-Adj. FCF -83.09 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — — —
Net Income -90.60 M -111.13 M -124.08 M -123.67 M -72.72 M
EPS (Diluted) -0.59 -1.31 -1.68 -2.76 —
Gross Profit — — — — —
Operating Income -93.33 M -115.95 M -131.19 M -125.62 M -72.81 M
EBITDA — — — — —
R&D Expenses 68.61 M 86.74 M 98.04 M 94.54 M 54.39 M
SG&A Expenses — — — — —
D&A 8.44 M 8.47 M 8.69 M 6.47 M 2.96 M
Interest Expense — — — — —
Income Tax 0.0 0.0 0.0 0.0 0.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 146.92 M 119.94 M 170.52 M 278.95 M 314.19 M
Total Liabilities 23.66 M 27.09 M 31.09 M 35.57 M 35.66 M
Shareholders' Equity 123.27 M 92.85 M 139.42 M 243.38 M 278.53 M
Total Debt — — — — —
Cash & Equivalents 100.55 M 4.32 M 45.68 M 95.27 M 38.13 M
Current Assets 105.59 M 67.38 M 111.58 M 193.75 M 255.36 M
Current Liabilities 15.44 M 15.98 M 22.73 M 24.25 M 21.77 M